MicroRNA-1297 Suppressed the Akt/GSK3 Signaling Pathway and Stimulated Neural Apoptosis in an Sevoflurane Exposure Model
Overview
Authors
Affiliations
Objective: Common inhalation anesthetics used for clinical anesthesia (such as sevoflurane) may induce nerve cell apoptosis during central nervous system development. Furthermore, anesthetics can produce cognitive impairments, such as learning and memory impairments, that continue into adulthood. However, the precise mechanism remains largely undefined. We aimed to determine the function of microRNA-1297 (miR-1297) in sevoflurane-induced neurotoxicity.
Methods: Reverse transcription-polymerase chain reaction assays were used to analyze miR-1297 expression in sevoflurane-exposed mice. MTT and lactate dehydrogenase (LDH) assays were used to measure cell growth, and neuronal apoptosis was analyzed using flow cytometry. Western blot analyses were used to measure PTEN, PI3K, Akt, and GSK3β protein expression.
Results: In sevoflurane-exposed mice, miR-1297 expression was up-regulated compared with the control group. MiR-1297 up-regulation led to neuronal apoptosis, inhibition of cell proliferation, and increased LDH activity in the model of sevoflurane exposure. MiR-1297 up-regulation also suppressed the Akt/GSK3β signaling pathway and induced PTEN protein expression in the model. PTEN inhibition (VO-Ohpic trihydrate) reduced PTEN protein expression and decreased the effects of miR-1297 down-regulation on neuronal apoptosis in the model.
Conclusion: Collectively, the results indicated that miR-1297 stimulates sevoflurane-induced neurotoxicity via the Akt/GSK3β signaling pathway by regulating PTEN expression.
Research advances on CaMKs-mediated neurodevelopmental injury.
Kong L, Yang J, Yang H, Xu B, Yang T, Liu W Arch Toxicol. 2024; 98(12):3933-3947.
PMID: 39292234 DOI: 10.1007/s00204-024-03865-5.
MicroRNAs-Based Theranostics against Anesthetic-Induced Neurotoxicity.
Minz R, Sharma P, Negi A, Kesari K Pharmaceutics. 2023; 15(7).
PMID: 37514018 PMC: 10385075. DOI: 10.3390/pharmaceutics15071833.
Zhao L, Wang Z, Chen H, Du Y, Ma W, Tao Q Mediators Inflamm. 2023; 2023:7750134.
PMID: 37064501 PMC: 10098412. DOI: 10.1155/2023/7750134.
Wang J, Liu Z Front Neurol. 2022; 13:1065976.
PMID: 36504660 PMC: 9729288. DOI: 10.3389/fneur.2022.1065976.
Zheng D, Zhou Y, Liu Y, Ma L, Meng L Evid Based Complement Alternat Med. 2022; 2022:8383315.
PMID: 35251215 PMC: 8894007. DOI: 10.1155/2022/8383315.